An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

PErsonalized TReatment for Endometrial Carcinoma

NCT05655260 ·Status: RECRUITING ·Phase: NA

Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer

NCT04830709 ·Status: RECRUITING

Sentinel Node Biopsy in Endometrial Cancer

NCT04073706 ·Status: RECRUITING ·Phase: PHASE3

Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma

NCT05364905 ·Status: COMPLETED

Molecular Staging of Endometrial Cancer

NCT00340808 ·Status: COMPLETED

OVArian Cancer Non-Interventional Study - OVATAR

NCT02122588 ·Status: COMPLETED

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

NCT04486352 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Expression Analysis of the COPB 2 and Bcl-2 in Early Stages of Endometrial Carcinoma

NCT05951426 ·Status: COMPLETED

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer

NCT00030485 ·Status: COMPLETED ·Phase: PHASE2

Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients

NCT01049126 ·Status: COMPLETED

Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery

NCT03373058 ·Status: UNKNOWN ·Phase: PHASE3

Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer

NCT04257786 ·Status: UNKNOWN ·Phase: NA

Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation

NCT05763472 ·Status: UNKNOWN

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

NCT03469674 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

NCT00005583 ·Status: COMPLETED ·Phase: PHASE3

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

NCT06989112 ·Status: RECRUITING ·Phase: PHASE3

BEZ235 Trial in Patients With Advanced Endometrial Carcinoma

NCT01290406 ·Status: WITHDRAWN ·Phase: PHASE2

Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

NCT03466788 ·Status: COMPLETED ·Phase: NA

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

NCT01244789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01074411 ·Status: COMPLETED ·Phase: PHASE1

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

NCT01307631 ·Status: COMPLETED ·Phase: PHASE2

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

NCT05691010 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

NCT01420081 ·Status: TERMINATED ·Phase: PHASE2

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

NCT00004251 ·Status: COMPLETED ·Phase: PHASE2

Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer

NCT00171808 ·Status: COMPLETED ·Phase: PHASE2